Sorafenib-plus-paclitaxel demonstrated a statistically significant improvement in the median time-to-progression, duration of response and objective response rate in comparison with paclitaxel ...
Pharmacogenomics. 2008;9(6):671-674. Paclitaxel (Taxol ®) has a broad activity spectrum and is clinically used, often in combination with carboplatin, to treat breast, ovarian and lung cancer.
Purpose: We assessed the safety, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D), efficacy, pharmacokinetic, and pharmacodynamics of the nilotinib-paclitaxel combination in 44 ...
Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback